Variables | non-CR-POPF | CR-POPF | t/Z/x2 | P-value |
---|---|---|---|---|
Gender | Â | Â | Â | Â |
Male | 103 (58.5%) | 21 (61.8%) | 0.124 | 0.725 |
Female | 73 (41.5%) | 13 (38.2%) | ||
Diabetes | Â | Â | Â | Â |
No | 140 (79.5%) | 29 (85.3%) | 0.599 | 0.439 |
Yes | 36 (20.5%) | 5 (14.7) | ||
Hypertension | Â | Â | Â | Â |
No | 136 (77.3%) | 25 (73.5%) | 0.233 | 0.637 |
Yes | 40 (20.5%) | 9 (26.5%) | ||
CHD | Â | Â | Â | Â |
No | 163 (92.6%) | 32 (94.1%) | 0.097 | 0.755 |
Yes | 13 (7.4%) | 2 (5.9%) | ||
Age(year) | 60.03 ± 10.45 | 59.44 ± 9.973 | 0.305 | 0.761 |
BMI(kg/m2) | 23.10 ± 3.15 | 24.62 ± 3.14 | −2.587 | 0.010* |
VR% | 85.95 ± 3.59 | 85.39 ± 3.68 | 0.811 | 0.418 |
LVEF | 61.46 ± 1.24 | 61.45 ± 1.12 | 0.011 | 0.991 |
WBC(109/L) | 6.38 ± 1.87 | 6.78 ± 2.25 | −1.090 | 0.277 |
Hb(g/L) | 120.54 ± 16.45 | 120.03 ± 19.36 | 0.161 | 0.872 |
PLT(109/L) | 250.27 ± 88.50 | 284.06 ± 66.08 | −2.084 | 0.038* |
LYMPH(109/L) | 1.47 ± 0.54 | 1.46 ± 0.47 | 0.118 | 0.960 |
MONO(109/L) | 0.55 ± 0.19 | 0.67 ± 0.25 | −3.146 | 0.002* |
NEUT(109/L) | 4.30 ± 2.01 | 4.65 ± 2.23 | −0.888 | 0.375 |
AST(U/L) | 67.50(31,140) | 94.50(51,152.25) | −1.875 | 0.021* |
ALT(U/L) | 96.0(41.25,189.75) | 145.0(63.75,229) | −0.888 | 0.034* |
GGT(U/L) | 425(98.5,688) | 702.5(225,104.25) | −2.312 | 0.061 |
ALP(U/L) | 323(160.5,510) | 507(259.5,709) | −2.116 | 0.217 |
PA(mg/L) | 162.09 ± 57.92 | 143.06 ± 43.73 | 1.738 | 0.084 |
ALB(g/L) | 37.07 ± 4.37 | 34.36 ± 7.01 | 2.920 | 0.004* |
TP(g/L) | 62.60(59.30,67.08) | 61.85(57.98,67.53) | −0.347 | 0.728 |
TBIL(μmol/L) | 106.6(31.5,209.25) | 159.7(63.77,299.65) | −2.140 | 0.032* |
Cr(μmol/L) | 52.4(36.1,65.4) | 58.3(50.35,67.85) | −1.323 | 0.186 |
BUN(μmol/L) | 5.10(4.10,9.70) | 5.25(4.30,6.20) | −0.382 | 0.703 |